Security key
59564R708
BIODEXA PHARMACEUTICALS PLC - SPON ADS NEW (BDRX)
CUSIP: 59564R708
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / SPON ADS NEW
- Total 13F shares
- 309,668
- Total 13F value
- $87,334
- Share change
- +158,221
- SEC-reported price per share
- $0.28
- Number of holders
- 6
- Value change
- -$24,866
- Number of buys
- 4
- Number of sells
- 7
Report period
Q3 2024
Institutions
6
Top holders
6
BDRX full security history
Ownership snapshot
Full 13F holder table
Biodexa Pharmaceuticals Plc SEC filings
Biodexa Pharmaceuticals Plc company facts
Broader feeds
Ownership snapshot
Top reported holders of BDRX - BIODEXA PHARMACEUTICALS PLC - SPON ADS NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Virtu Financial LLC
Disclosed value leader
Virtu Financial LLC
Comparable rows
0/12
Latest evidence
30 Jun 2024
13F
Highest disclosed value: $32,000
12 rows are not safely comparable across share classes.
Showing 1-6 of 12 holder rows.
Quick read
Virtu Financial LLC has the largest disclosed position value at $32K.
0 of 12 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Virtu Financial LLC's linked filing trail.
Disclosed position value
Top 5
Virtu Financial LLC
$32K
CITADEL ADVISORS LLC
$30K
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$27K
TWO SIGMA SECURITIES, LLC
$18.4K
Ground Swell Capital, LLC
$11.7K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 12 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Virtu Financial LLC |
13F
Company
|
—
denominator unverified
|
$32,000
35,776 shares
|
— | 30 Jun 2024 |
| CITADEL ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$29,960
33,441 shares
|
— | 30 Jun 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
—
denominator unverified
|
$26,979
30,114 shares
|
— | 30 Jun 2024 |
| TWO SIGMA SECURITIES, LLC |
13F
Company
|
—
denominator unverified
|
$18,417
20,557 shares
|
— | 30 Jun 2024 |
| Ground Swell Capital, LLC |
13F
Company
|
—
denominator unverified
|
$11,717
13,078 shares
|
— | 30 Jun 2024 |
| UBS Group AG |
13F
Company
|
—
denominator unverified
|
$8,957
9,997 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
6
Shares
309,668
Rows available
6
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
12
Q3 2024 holders
6
Holder diff
-6
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|